Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a double-blind, randomized, placebo-controlled, multicenter clinical trial in which 18 patients affected with chronic traumatic incomplete cervical spinal cord injury will be randomized to either the active treatment (2 doses of intrathecal WJ-MSC 3 months apart) or to placebo (2 intrathecal infusions, 3 months apart). Thereafter, patients will be followed-up for 12 months for safety and efficacy assessment.
Epistemonikos ID: e3c02b584f7b87184f9d23a715e2af5ca42b61af
First added on: May 09, 2024